148 related articles for article (PubMed ID: 15683227)
1. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.
Pan Y; Ma B; Venkataraghavan RB; Levine AJ; Nussinov R
Biochemistry; 2005 Feb; 44(5):1423-32. PubMed ID: 15683227
[TBL] [Abstract][Full Text] [Related]
2. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
[TBL] [Abstract][Full Text] [Related]
3. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
5. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
[TBL] [Abstract][Full Text] [Related]
6. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.
Mateu MG; Fersht AR
EMBO J; 1998 May; 17(10):2748-58. PubMed ID: 9582268
[TBL] [Abstract][Full Text] [Related]
7. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
[TBL] [Abstract][Full Text] [Related]
8. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
[TBL] [Abstract][Full Text] [Related]
9. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay.
Maurici D; Monti P; Campomenosi P; North S; Frebourg T; Fronza G; Hainaut P
Oncogene; 2001 Jun; 20(27):3533-40. PubMed ID: 11429700
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.
Bullock AN; Henckel J; Fersht AR
Oncogene; 2000 Mar; 19(10):1245-56. PubMed ID: 10713666
[TBL] [Abstract][Full Text] [Related]
11. Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.
Duan J; Nilsson L
Biochemistry; 2006 Jun; 45(24):7483-92. PubMed ID: 16768444
[TBL] [Abstract][Full Text] [Related]
12. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Kato S; Han SY; Liu W; Otsuka K; Shibata H; Kanamaru R; Ishioka C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8424-9. PubMed ID: 12826609
[TBL] [Abstract][Full Text] [Related]
13. Role of the amino acid sequence in domain swapping of the B1 domain of protein G.
Sirota FL; Héry-Huynh S; Maurer-Stroh S; Wodak SJ
Proteins; 2008 Jul; 72(1):88-104. PubMed ID: 18186476
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
Joerger AC; Allen MD; Fersht AR
J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
[TBL] [Abstract][Full Text] [Related]
15. Kinetic computational alanine scanning: application to p53 oligomerization.
Chong LT; Swope WC; Pitera JW; Pande VS
J Mol Biol; 2006 Mar; 357(3):1039-49. PubMed ID: 16457841
[TBL] [Abstract][Full Text] [Related]
16. Structure and functionality of a designed p53 dimer.
Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic effects of proline introduction on protein stability.
Prajapati RS; Das M; Sreeramulu S; Sirajuddin M; Srinivasan S; Krishnamurthy V; Ranjani R; Ramakrishnan C; Varadarajan R
Proteins; 2007 Feb; 66(2):480-91. PubMed ID: 17034035
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.
Nikolova PV; Wong KB; DeDecker B; Henckel J; Fersht AR
EMBO J; 2000 Feb; 19(3):370-8. PubMed ID: 10654936
[TBL] [Abstract][Full Text] [Related]
19. Exploring sequence/folding space: folding studies on multiple hydrophobic core mutants of ubiquitin.
Benítez-Cardoza CG; Stott K; Hirshberg M; Went HM; Woolfson DN; Jackson SE
Biochemistry; 2004 May; 43(18):5195-203. PubMed ID: 15122885
[TBL] [Abstract][Full Text] [Related]
20. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods.
Mathe E; Olivier M; Kato S; Ishioka C; Hainaut P; Tavtigian SV
Nucleic Acids Res; 2006; 34(5):1317-25. PubMed ID: 16522644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]